Status:
COMPLETED
Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study
Lead Sponsor:
Bristol-Myers Squibb
Collaborating Sponsors:
Heidelberg University
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to estimate the incidence rates of Post-transplant Lymphoproliferative Disorder (PTLD), malignancy and hospitalized infections in adult kidney-only transplant recipients tr...
Detailed Description
Time Perspective: Prospective design, Retrospective data collection and analysis
Eligibility Criteria
Inclusion
- 1st kidney only transplant during study, at one of the transplant centers participating in CTS, received Belatacept or a CNI at the time of transplantation
Exclusion
- Patients with a history of malignancy
Key Trial Info
Start Date :
March 31 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 8 2017
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT01471223
Start Date
March 31 2012
End Date
August 8 2017
Last Update
September 19 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.